Brief: NextCure Publishes Preclinical Data Demonstrating Function Of FLRT3 As T Cell Inhibitor In Science Advances
05/03/2024 15:03
March 5 (Reuters) - NextCure Inc NXTC.O :
* NEXTCURE PUBLISHES PRECLINICAL DATA DEMONSTRATING FUNCTION
OF
FLRT3 AS A T CELL INHIBITOR IN SCIENCE ADVANCES
Source text for Eikon: ID:nGNX6924MX
Further company coverage: NXTC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NextCure
See all newsBrief: Xcellon Biologics Co Acquires Gmp Manufacturing Facility From Nextcure
NextCure Inc reports results for the quarter ended June 30 - Earnings Summary
NextCure Q2 net loss narrows on lower expenses
Brief: NextCure Q2 Net Income USD -14.892 Million
NextCure Inc expected to post a loss of $1.93 a share - Earnings Preview